An investigation on behalf of investors in McKesson Corporation (NYSE:MCK) shares over potential wrongdoing at McKesson was announced and NYSE:MCK stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/17/2014 -- An investigation on behalf of current long-term investors in shares of McKesson Corporation (NYSE:MCK) shares was announced over potential breaches of fiduciary duties by certain officers and directors at McKesson.
Investors who purchased shares of McKesson Corporation (NYSE:MCK) and currently hold any of those NYSE:MCK shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain McKesson officers and directors breached their fiduciary duties and caused damage to the company and its shareholders. More specifically, investigation concerns whether McKesson Corporation submitted allegedly false claims to the Centers for Disease Control and Prevention (CDC) under its vaccine distribution contract by improperly setting temperature monitors used in shipping the vaccines.
McKesson Corporation reported tat its Total Revenue rose from over $122.06 billion for the 12 months period that ended on March 31, 3013 to over $137.6 billion for the 12 months period that neded on March 31, 2014, while its respective Net Income declined from over $1.33 billion to over $1.26 billion.
Shares of McKesson Corporation (NYSE:MCK) grew from under $100 per share in early 2013 to as high as $214.06 per share on December 8, 2014.
On December 15, 2014, NYSE:MCK shares closed at $206.40 per share.
Those who purchased shares of McKesson Corporation (NYSE:MCK) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego